Cargando…

Atrial Natriuretic Peptides as a Bridge between Atrial Fibrillation, Heart Failure, and Amyloidosis of the Atria

ANP is mainly synthesized by the atria, and upon excretion, it serves two primary purposes: vasodilation and increasing the renal excretion of sodium and water. The understanding of ANP’s role in cardiac systems has improved considerably in recent decades. This review focuses on several studies demo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rahbar Kouibaran, Farzad, Sabatino, Mario, Barozzi, Chiara, Diemberger, Igor
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10095038/ https://www.ncbi.nlm.nih.gov/pubmed/37047444 http://dx.doi.org/10.3390/ijms24076470

Ejemplares similares

Sibjotang Increases Atrial Natriuretic Peptide Secretion in Beating Rabbit Atria
por: Kwon, Oh Jeong, et al.
Publicado: (2015)

Clinical Applications of Natriuretic Peptides in Heart Failure and Atrial Fibrillation
por: Baba, Masako, et al.
Publicado: (2019)

Natriuretic peptides for the detection of paroxysmal atrial fibrillation
por: Seegers, Joachim, et al.
Publicado: (2015)

Profibrotic, Electrical, and Calcium-Handling Remodeling of the Atria in Heart Failure Patients With and Without Atrial Fibrillation
por: Molina, Cristina E., et al.
Publicado: (2018)

Novel Methods for Characterization of Paroxysmal Atrial Fibrillation in Human Left Atria
por: Zhao, Jichao, et al.
Publicado: (2013)

Ethanol Extract of Lepidium apetalum Seed Elicits Contractile Response and Attenuates Atrial Natriuretic Peptide Secretion in Beating Rabbit Atria
por: Kim, Seung Ju, et al.
Publicado: (2013)

Atrial Natriuretic Peptide Single Nucleotide Polymorphisms in Patients with Nonfamilial Structural Atrial Fibrillation
por: Francia, Pietro, et al.
Publicado: (2013)

N-terminal Pro-Brain Natriuretic Peptide And Atrial Fibrillation
por: Thejus, Jayachandran, et al.
Publicado: (2009)

Optimizing indices of atrial fibrillation susceptibility and burden to evaluate atrial fibrillation severity, risk and outcomes
por: Boriani, Giuseppe, et al.
Publicado: (2021)

Driver characteristics associated with structurally and electrically remodeled atria in persistent atrial fibrillation
por: Dhillon, Gurpreet Singh, et al.
Publicado: (2022)

Interactions Between Atrial Fibrillation and Natriuretic Peptide in Predicting Heart Failure Hospitalization or Cardiovascular Death
por: Brady, Paul F., et al.
Publicado: (2022)

Relationship of atrial fibrillation and N terminal pro brain natriuretic peptide in heart failure patients
por: Nasab Mehrabi, Entezar, et al.
Publicado: (2023)

Efficacy of exogenous atrial natriuretic peptide in patients with heart failure with preserved ejection fraction: deficiency of atrial natriuretic peptide and replacement therapy
por: Matsumoto, Shingo, et al.
Publicado: (2020)

Do the Natriuretic Peptides Cause Atrial Fibrillation or is it Not So Black and White?
por: Richards, Arthur Mark
Publicado: (2019)

Publisher’s note to: Optimizing indices of atrial fibrillation susceptibility and burden to evaluate atrial fibrillation severity, risk and outcomes
por: Boriani, Giuseppe, et al.
Publicado: (2022)

Transcriptome and proteome mapping in the sheep atria reveal molecular featurets of atrial fibrillation progression
por: Alvarez-Franco, Alba, et al.
Publicado: (2020)

Stability of High‐Quality Warfarin Anticoagulation in a Community‐Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study
por: Dallalzadeh, Liane O., et al.
Publicado: (2016)

Interplay between natriuretic peptides and left atrial mechanics and the relation to recurrence of atrial fibrillation following catheter ablation
por: Olsen, Flemming Javier, et al.
Publicado: (2023)

Significance of Atrial and Brain Natriuretic Peptide Measurements in Fetuses With Heart Failure
por: Miyoshi, Takekazu, et al.
Publicado: (2021)

Assessment of causality of natriuretic peptides and atrial fibrillation and heart failure: a Mendelian randomization study in the FINRISK cohort
por: Geelhoed, Bastiaan, et al.
Publicado: (2020)

Atrial fibrillation alters the microRNA expression profiles of the left atria of patients with mitral stenosis
por: Liu, Hai, et al.
Publicado: (2014)

Erratum to: Transcriptome and proteome mapping in the sheep atria reveal molecular features of atrial fibrillation progression
por: Alvarez-Franco, Alba, et al.
Publicado: (2021)

Critical Link between Calcium Regional Heterogeneity and Atrial Fibrillation Susceptibility in Sheep Left Atria
por: Niort, Barbara C., et al.
Publicado: (2023)

ScaI atrial natriuretic peptide gene polymorphisms and their possible association with postoperative atrial fibrillation – a preliminary report
por: Siebert, Janusz, et al.
Publicado: (2016)

Brain Natriuretic Peptide Is a Powerful Predictor of Outcome in Stroke Patients with Atrial Fibrillation
por: Maruyama, Kenji, et al.
Publicado: (2017)

Atrial Natriuretic Peptide and Adiponectin Interactions in Man
por: Birkenfeld, Andreas L., et al.
Publicado: (2012)

Awareness of atrial fibrogenesis and natriuretic peptide release
por: Meijers, W. C. F. W., et al.
Publicado: (2017)

Heart failure with preserved ejection fraction, atrial fibrillation, and the role of senile amyloidosis
por: van den Berg, Maarten P, et al.
Publicado: (2019)

Atrial fibrillation in patients with cardiac amyloidosis and heart failure: a desperate cause?
por: Sellal, Jean-Marc, et al.
Publicado: (2023)

N‐terminal pro brain natriuretic peptide eliminates the prognostic effect of atrial fibrillation in patients with chronic heart failure
por: Schnorbach, Johannes, et al.
Publicado: (2019)

Run baby run … but not too fast! Rate control management in atrial fibrillation: a claim for personalization
por: Diemberger, Igor, et al.
Publicado: (2023)

Glycogen and the Propensity for Atrial Fibrillation: Intrinsic Anatomic Differences in Glycogen in the Left and Right Atria in the Goat Heart
por: Embi, Abraham A., et al.
Publicado: (2014)

VLDL from Metabolic Syndrome Individuals Enhanced Lipid Accumulation in Atria with Association of Susceptibility to Atrial Fibrillation
por: Lee, Hsiang-Chun, et al.
Publicado: (2016)

Heterogeneous Effects of Fibroblast-Myocyte Coupling in Different Regions of the Human Atria Under Conditions of Atrial Fibrillation
por: Sánchez, Jorge, et al.
Publicado: (2019)

Anatomy of the atria: A road map to the left atrial appendage
por: Barbero, Umberto, et al.
Publicado: (2017)

Are the atrial natriuretic peptides a missing link predicting low‐voltage areas in atrial fibrillation? Introducing the novel biomarker‐based atrial fibrillation substrate prediction (ANP) score
por: Seewöster, Timm, et al.
Publicado: (2020)

Effects of Persistent Atrial Fibrillation-Induced Electrical Remodeling on Atrial Electro-Mechanics – Insights from a 3D Model of the Human Atria
por: Adeniran, Ismail, et al.
Publicado: (2015)

Pre-ablation levels of brain natriuretic peptide are independently associated with the recurrence of atrial fibrillation after radiofrequency catheter ablation in patients with nonvalvular atrial fibrillation
por: Miake, Junichiro, et al.
Publicado: (2018)

The role of brain natriuretic peptide in atrial fibrillation: a substudy of the Substrate Modification with Aggressive Blood Pressure Control for Atrial Fibrillation (SMAC-AF) trial
por: Weng, Willy, et al.
Publicado: (2021)

Prevalence of Atrial Fibrillation and Antithrombotic Therapy in Hemodialysis Patients: Cross-Sectional Results of the Vienna InVestigation of AtriaL Fibrillation and Thromboembolism in Patients on HemoDIalysis (VIVALDI)
por: Königsbrügge, Oliver, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_qep2jsebshoc8qu5dsl00okben